Remdesivir Is Probably a Reproductive Toxin, and Its Benefit Is Unclear
chrismasterjohnphd.substack.com
On April 29, the NIH's National Institute of Allergy and Infectious Disease (NIAID), headed by Dr. Anthony Fauci, announced promising preliminary results of its clinical trial testing the effect of remdesivir in COVID-19 patients. The study has not been released even as a preprint.* Fauci
Remdesivir Is Probably a Reproductive Toxin, and Its Benefit Is Unclear
Remdesivir Is Probably a Reproductive Toxin…
Remdesivir Is Probably a Reproductive Toxin, and Its Benefit Is Unclear
On April 29, the NIH's National Institute of Allergy and Infectious Disease (NIAID), headed by Dr. Anthony Fauci, announced promising preliminary results of its clinical trial testing the effect of remdesivir in COVID-19 patients. The study has not been released even as a preprint.* Fauci